Alexander Kraus, PhD.
Vice President of Product Development,
Technical & Government Affairs
Dr. Alexander Kraus is Vice President of Product Development, Technical & Government Affairs for our Business Unit North America. He is responsible for R&D related aspects for all partnered products including those utilizing Grünenthal's INTAC® technology. Further, he is driving US Public and Government relations activities around abuse prevention and the use of abuse-deterrent technologies for opioids and other abused prescription drugs.
Dr. Kraus joined Grünenthal’s corporate headquarters in Aachen, Germany in 1999 as a scientist in the Pharmacokinetics department. From 2001 to 2009 he served as the head of that department. During this time Dr. Kraus was involved with Grünenthal's preclinical advisory boards and steering committees for R&D. In 2006, he became the Division Deputy Head of Preclinical Drug Development. In 2009, Dr. Kraus joined Grünenthal USA, Inc. as Chief Scientific Officer. He later was appointed COO and then CEO. In July 2011, Dr. Kraus was appointed Head TRF Program Management with the goal to grow Grünenthal's INTAC business in the US. Dr. Kraus was appointed to his current position in April 2013, when Grünenthal established the Business Unit North America, supporting activities related to the licensing business for products and its INTAC® technology in the US.
Dr. Kraus received his degree in Chemistry and later achieved a PhD in Physical Chemistry from the University of Cologne, Germany.